First Time Loading...

United Therapeutics Corp
NASDAQ:UTHR

Watchlist Manager
United Therapeutics Corp Logo
United Therapeutics Corp
NASDAQ:UTHR
Watchlist
Price: 272.69 USD 1.08% Market Closed
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

6.5B
-9%
Assets
Growth Rates:
1 Year
+2%
3 Years
+40%
5 Years
+74%
7 Years
+154%
10 Years
+207%
1.2B
-2%
Liabilities
Growth Rates:
1 Year
-5%
3 Years
-3%
5 Years
-17%
7 Years
+139%
10 Years
+53%
5.3B
-11%
Equity
Growth Rates:
1 Year
+4%
3 Years
+55%
5 Years
+128%
7 Years
+157%
10 Years
+293%

Balance Sheet Decomposition
United Therapeutics Corp

6.5B
Assets
1.2B
Liabilities
6.5B
Assets
1.2B
Liabilities
Current Assets 3.2B
Cash & Short-Term Investments 2.7B
Receivables 307.3m
Other Current Assets 233.6m
Non-Current Assets 3.2B
Long-Term Investments 1.5B
PP&E 1.1B
Intangibles 115.4m
Other Non-Current Assets 565.2m
Current Liabilities 860.6m
Accounts Payable 305.1m
Other Current Liabilities 555.5m
Non-Current Liabilities 296.5m
Long-Term Debt 200m
Other Non-Current Liabilities 96.5m

Balance Sheet
United Therapeutics Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
398
832
1 023
705
669
738
739
895
961
1 208
Cash Equivalents
398
832
1 023
705
669
738
739
895
961
1 208
Short-Term Investments
298
122
28
222
747
748
1 096
1 036
1 878
1 786
Total Receivables
162
193
215
297
176
151
157
199
220
279
Accounts Receivables
162
193
215
297
176
151
157
199
220
279
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
67
81
100
108
101
93
87
94
102
112
Other Current Assets
49
47
60
116
75
134
88
100
219
166
Total Current Assets
974
1 275
1 425
1 448
1 768
1 865
2 167
2 324
3 380
3 551
PP&E Net
478
496
489
546
700
743
732
781
862
1 045
PP&E Gross
478
496
489
546
700
743
732
781
862
1 045
Accumulated Depreciation
135
155
175
203
235
269
309
342
383
428
Intangible Assets
19
18
24
32
139
130
130
17
17
81
Goodwill
10
10
10
14
32
28
28
28
28
34
Long-Term Investments
123
38
2
503
443
768
1 150
1 650
1 316
1 938
Other Long-Term Assets
280
347
375
338
320
380
409
370
442
518
Other Assets
10
10
10
14
32
28
28
28
28
34
Total Assets
1 884
N/A
2 184
+16%
2 326
+6%
2 879
+24%
3 401
+18%
3 913
+15%
4 615
+18%
5 169
+12%
6 045
+17%
7 167
+19%
Liabilities
Accounts Payable
7
8
8
8
23
10
4
4
4
6
Accrued Liabilities
71
88
96
163
143
140
183
171
226
292
Short-Term Debt
127
5
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
250
0
0
0
400
Other Current Liabilities
300
340
228
274
111
63
136
131
113
106
Total Current Liabilities
504
441
333
445
277
463
323
305
343
804
Long-Term Debt
0
0
0
250
250
600
800
800
800
300
Other Liabilities
115
144
131
64
67
70
97
105
105
78
Total Liabilities
619
N/A
585
-5%
463
-21%
758
+64%
593
-22%
1 133
+91%
1 220
+8%
1 210
-1%
1 248
+3%
1 182
-5%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
1 068
1 720
2 434
2 846
3 435
3 325
3 839
4 315
5 042
6 027
Additional Paid In Capital
1 376
1 791
1 814
1 854
1 940
2 048
2 149
2 245
2 388
2 549
Unrealized Security Profit/Loss
0
0
0
2
2
4
10
5
56
11
Treasury Stock
1 186
1 902
2 380
2 579
2 579
2 579
2 579
2 579
2 579
2 579
Other Equity
6
9
6
2
14
18
25
18
1
2
Total Equity
1 266
N/A
1 600
+26%
1 862
+16%
2 121
+14%
2 808
+32%
2 780
-1%
3 395
+22%
3 959
+17%
4 797
+21%
5 985
+25%
Total Liabilities & Equity
1 884
N/A
2 184
+16%
2 326
+6%
2 879
+24%
3 401
+18%
3 913
+15%
4 615
+18%
5 169
+12%
6 045
+17%
7 167
+19%
Shares Outstanding
Common Shares Outstanding
47
46
43
43
44
44
45
45
46
47

See Also

Summary
UTHR intrinsic value, competitors valuation, and company profile.
DCF Valuation
UTHR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UTHR stock valuation using valuation multiples.
Wall Street Estimates
UTHR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UTHR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.